A type II latency pattern of EBV infection has been observed in ENKTL patients, whereby tumor cells express EBERs, EBV nuclear antigen-1 (EBNA-1), latent membrane protein (LMP)-1, and LMP-2. This evidence concerns the gene PSMB9 and neoplasm.